日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CT-P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, Active-Controlled, Phase 3 Study

CT-P39 与参考药物奥马珠单抗治疗慢性自发性荨麻疹的比较:一项双盲、随机、阳性对照的 3 期研究结果

Saini, Sarbjit S; Maurer, Marcus; Dytyatkovska, Yevgeniya; Springer, Ewa; Ratkova, Maria; Krusheva, Borislava; Park, Chun Wook; Pulka, Grazyna; Chełmińska, Marta; Reich, Adam; Kim, Sunghyun; Ahn, Keumyoung; Kim, Suyoung; Lee, Sewon; Ka, Jieun; Kim, Jongho; Grattan, Clive

Multiple Switches Between Adalimumab-fkjp and Reference Adalimumab in Moderate-to-Severe Chronic Plaque Psoriasis: A Multicenter, Double-Blind, Parallel Group, Randomized Clinical Trial for Interchangeability

在中重度慢性斑块状银屑病中,多次切换使用阿达木单抗-fkjp和参考阿达木单抗:一项多中心、双盲、平行组、随机临床试验,旨在评估其互换性。

Deodhar, Sarika; Loganathan, Subramanian; Kadadanamari Subbarama Reddy, Ramesh; Ranganna, Gopinath M; Liu, Shiyao; Hummel, Matthew A; Daniluk, Stefan; Hanczewska, Anna; Vekovska, Kamelia; Zegadlo-Mylik, Maria; Pulka, Grazyna; -Holz, Elena Wolff

Efficacy and safety of CT-P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16-week follow-up study

CT-P39(一种奥马珠单抗生物类似药)治疗慢性自发性荨麻疹的疗效和安全性:16周随访研究

Grattan, Clive; Dytyatkovska, Yevgeniya; Springer, Michał; Ratkova, Maria; Krusheva, Borislava; Krupa-Borek, Izabella; Pulka, Grazyna; Chełmińska, Marta; Reich, Adam; Kim, Sunghyun; Bae, Yunju; Kim, Suyoung; Lee, Sewon; An, Eunjin; Park, Jeong Eun; Ka, Jieun; Kim, Jongho; Saini, Sarbjit S

Mechanistic Insights into Lipooligourea-Lipid Membrane Interactions

利普利戈脲与脂质膜相互作用的机制研究

Burdach, Kinga; Reterska, Zuzanna; Grempka, Arkadiusz; Dziubak, Damian; Juhaniewicz-Dębińska, Joanna; Bachurska-Szpala, Paulina; Pulka-Ziach, Karolina; Sęk, Sławomir

Stimuli-Responsive Oligourea Molecular Films

刺激响应型寡脲分子膜

Grempka, Arkadiusz; Dziubak, Damian; Puszko, Anna K; Bachurska-Szpala, Paulina; Ivanov, Maxim; Vilarinho, Paula M; Pulka-Ziach, Karolina; Sek, Slawomir

Caregiver-reported barriers to engagement in a paediatric fresh fruit and vegetable prescription programme

照护者报告的参与儿童新鲜水果和蔬菜处方计划的障碍

Saxe-Custack, Amy; Egan, Sarah; Farmer, Bridget; Pulka, Kimberly; Sampson, Anna

Phase 2b randomized trial of OX40 inhibitor telazorlimab for moderate-to-severe atopic dermatitis

OX40抑制剂telazorlimab治疗中重度特应性皮炎的IIb期随机试验

Rewerska, Barbara; Sher, Lawrence D; Alpizar, Sady; Pauser, Sylvia; Pulka, Grazyna; Mozaffarian, Neelufar; Salhi, Yacine; Martinet, Camille; Jabert, Wafaa; Gudi, Girish; Ca, Vinu; Gn, Sunitha; Macoin, Julie; Anstett, Victor; Turrini, Riccardo; Doucey, Marie-Agnès; Blein, Stanislas; Konto, Cyril; Machkova, Martina

Variances in the Expression Profile of Circadian Clock-Related Genes in Astrocytic Brain Tumors

星形细胞脑肿瘤中昼夜节律相关基因表达谱的差异

Rafał Staszkiewicz, Dawid Sobański, Wojciech Pulka, Dorian Gładysz, Marcin Gadzieliński, Damian Strojny, Beniamin Oskar Grabarek

Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study

比拉斯汀0.6%滴眼液的安全性和耐受性:一项为期8周的III期研究

Kuna, Piotr; Jutel, Marek; Pulka, Grazyna; Tokarski, Slawomir; Arranz, Paula; Hernández, Gonzalo; Fernández Hernando, Nieves

Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study

AVT02 与原研药阿达木单抗在治疗中重度慢性斑块状银屑病患者中的疗效、安全性和免疫原性:一项多中心、双盲、随机、平行组、活性对照的 III 期研究

Feldman, Steven R; Reznichenko, Nataliya; Pulka, Grazyna; Kingo, Külli; George Galdava; Berti, Fausto; Sobierska, Joanna; Dias, Roshan; Guenzi, Eric; Hendrik Otto; Haliduola, Halimu N; Kay, Richard; Stroissnig, Heimo